Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-22

Clinical Trial Update: Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss in Sites Across the United Kingdom [NA]

View source ↗

Summary

This entry reports a clinical trial update for the Librata Endometrial Ablation Device aimed at reducing heavy menstrual bleeding across sites in the United Kin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Librata Endometrial Ablation Device

Snippet

Sponsor: Birmingham Women's NHS Foundation Trust | Conditions: Heavy Menstrual Bleeding | NA | Status: UNKNOWN